ADIPOQ and polycystic ovary syndrome: When PCOS and non-PCOS NAFLD groups were compared, no difference in the levels of resistin, adiponectin and insulin were observed, thus, confirming the findings of others [29,30] and pointing to the fact that the levels of these hormones are defined by underlying metabolic states and patient’s BMI, rather than by PCOS.